Latest / Let's Talk Risk! Podcast
Deep Dive: What FDA’s QMSR Warning Letters Are Revealing
If you’re trying to manage risk in isolated silos, your quality management system is already obsolete.
What happens when a supplier changes a device label without triggering design controls? When operators quietly rework nonconforming product? Or when serious post-market signals never make it back into the risk file?
This Deep Dive examines recent FDA inspection and warning-letter examples through one common lens: the integration of risk management across the quality system.
The cases illustrate how seemingly separate failures in supplier controls, manufacturing, complaints, nonconforming…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.